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Abstract 
Background: Extracellular vesicles (EVs) have been broadly studied in malaria for nearly a decade. These vesicles 
carry various functional biomolecules including RNA families such as microRNAs (miRNA). These EVs-derived microR-
NAs have numerous roles in host-parasite interactions and are considered promising biomarkers for disease severity. 
However, this field lacks clinical studies of malaria-infected samples. In this study, EV specific miRNAs were isolated 
from the plasma of patients from Thailand infected with Plasmodium vivax and Plasmodium falciparum. In addition, it is 
postulated that these miRNAs were differentially expressed in these groups of patients and had a role in disease onset 
through the regulation of specific target genes.
Methods: EVs were purified from the plasma of Thai P. vivax-infected patients (n = 19), P. falciparum-infected patients 
(n = 18) and uninfected individuals (n = 20). EV-derived miRNAs were then prepared and abundance of hsa-miR-
15b-5p, hsa-miR-16-5p, hsa-let-7a-5p and hsa-miR-150-5p was assessed in these samples. Quantitative polymerase 
chain reaction was performed, and relative expression of each miRNA was calculated using hsa-miR-451a as endog-
enous control. Then, the targets of up-regulated miRNAs and relevant pathways were predicted by using bioinformat-
ics. Receiver Operating Characteristic with Area under the Curve (AUC) was then calculated to assess their diagnostic 
potential.
Results: The relative expression of hsa-miR-150-5p and hsa-miR-15b-5p was higher in P. vivax-infected patients com-
pared to uninfected individuals, but hsa-let-7a-5p was up-regulated in both P. vivax-infected patients and P. falcipa-
rum-infected patients. Bioinformatic analysis revealed that these miRNAs might regulate genes involved in the malaria 
pathway including the adherens junction and the transforming growth factor-β pathways. All up-regulated miRNAs 
could potentially be used as disease biomarkers as determined by AUC; however, the sensitivity and specificity require 
further investigation.
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
Malaria Journal
*Correspondence:  valery.combes@uts.edu.au; nantadao@gmail.com
†Nutpakal Ketprasit and Iris Simone Cheng are co-first authors
†Valery Combes and Duangdao Palasuwan are co-senior authors
2 Malaria and Microvesicles Research Group, School of Life Sciences, 
Faculty of Sciences, University Technology of Sydney, Ultimo, Sydney, 
NSW 2007, Australia
5 Oxidation in Red Cell Disorders Research Unit, Department of Clinical 
Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, 
154 Rama 1 Road, Pathumwan, Bangkok 10330, Thailand
Full list of author information is available at the end of the article
Page 2 of 14Ketprasit et al. Malar J          (2020) 19:285 
Background
According to the World Health Organization (WHO) 
World Malaria Report 2019, there were an estimated 
405,000 deaths, and 228 million cases were reported 
globally [1]. Plasmodium vivax has the highest preva-
lence and is known to cause relapse infection [2], whereas 
P. falciparum is the most virulent species causing severe 
syndromes. Malaria appears to be more devastating 
worldwide as the emergence of artemisinin-resistant 
malaria parasites [3, 4]. To overcome the disease, novel 
drug development is essential. On the other hand, in-
depth understanding of the parasite biology and mecha-
nisms underlying the disease is also urgently needed.
Extracellular vesicles (EVs), which are small mem-
brane-bound vesicles, have been explored in malaria for 
the last decade. Classification of EVs is based on their 
cellular origin, size, and biological functions [5]. Two 
major types of EVs have been studied broadly including 
microvesicles (previously named microparticles) and 
exosomes. Another type of EVs are the apoptotic bod-
ies which are released during the apoptotic process [6]. 
Microvesicles are vesicles that bleb from the cell mem-
brane whereas exosomes are released from multivesicu-
lar bodies (MVBs) through an exocytotic process in the 
endolysosomal pathway [7].
Typically, EVs can be detected in very low numbers 
in healthy individuals. However, upon activation which 
is triggered by various pathological conditions [8–11], 
the number of EVs present in biological fluids increases. 
Various biomolecules were identified in EVs such as pro-
teins, lipids, and nucleic acids [12]. Such biomolecules 
entrapped in EVs play many important roles in intercel-
lular communication in numerous diseases, including 
malaria [13, 14].
EVs numbers have been shown to increase during 
malaria infection both in patients and in experimen-
tal malaria models [10, 11, 15–18]. They are associated 
with either protective [19] or enhanced pathogenicity 
of malaria infection [11, 16–18, 20, 21]. The most com-
mon feature demonstrated in malaria is that EVs can 
act as immunomodulators. EVs from infected-erythro-
cytes can stimulate innate immune cells including mac-
rophages [22], natural killer cells [23], monocytes and 
neutrophils [24]. Interestingly, EVs participate in cell–cell 
communication between parasites and parasites or host 
cells. Exosome-like vesicles have played a role in game-
tocytogenesis, which is crucial for malaria transmission, 
and these small membrane-bound vesicles could trans-
fer drug-resistance markers to drug-sensitive parasites 
[25]. Additionally, EVs which cargo P. falciparum lactate 
dehydrogenase (PfLDH) could control parasite density 
in  vitro [26]. One study also showed that EVs enriched 
with the parasite’s genomic DNA, released from infected 
red blood cells could be internalized by monocytes and 
elicited an innate immune response [27].
As mentioned above, EVs carry many kinds of biomol-
ecules including microRNAs (miRNAs). EVs were shown 
to protect the miRNAs from RNases-mediated degra-
dation and EVs-entrapped miRNAs were also demon-
strated to have regulatory functions [28–30]. MiRNAs 
are members of the non-coding RNAs family which were 
first discovered in Caenorhabditis elegans [31]. Malaria 
parasites do not express specific miRNAs [32, 33], as 
Dicer or Argonaut encoding genes are not found in these 
parasites [34–36]. However, several studies showed that 
miRNAs could translocate to P. falciparum [37, 38]. A 
pioneer investigation by Lamonte et  al. showed interac-
tion between human miRNAs and P. falciparum, where 
the expression of hsa-miR-451a and hsa-let-7i were 
increased in sickle cells. These miRNAs could inhibit par-
asitic protein translation resulting in low proliferation of 
parasites [38]. In other studies, expression of miRNAs in 
heart and brain tissues from mice with cerebral malaria 
were shown to be dysregulated when compared to non-
cerebral malaria [39, 40].
MiRNAs, human Argonaute protein and RISC com-
plex could be detected in the parasites [37] as well as 
in EVs released by infected erythrocytes [41, 42]. EVs 
carried Argonaut-miRNAs complex affecting recipi-
ent cells that have been demonstrated to alter vascu-
lar function [41] or the parasite’s var gene expression 
[43]. These studies strengthen the roles of EVs-derived 
miRNAs in malaria pathogenesis. There are only three 
studies that have analysed miRNAs in malaria-infected 
patients. In human plasma samples, the expression of 
hsa-miR-451a and hsa-miR-16 in P. vivax-infected 
patients were lower than those in P. falciparum-
infected patients. Moreover, hsa-miR-451a and hsa-
miR-16 had a negative relationship with parasitaemia 
[44]. In a post-mortem study, the expression of various 
Conclusion: An upregulation of hsa-miR-150-5p and hsa-miR-15b-5p was observed in P. vivax-infected patients while 
hsa-let-7a-5p was up-regulated in both P. vivax-infected and P. falciparum-infected patients. These findings will require 
further validation in larger cohort groups of malaria patients to fully understand the contribution of these EVs miRNAs 
to malaria detection and biology.
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miRNAs were found to be differentially expressed 
between malaria and non-malaria deaths [45]. Further-
more, hsa-miR-146a was newly predicted to play a role 
in innate immunity in pregnancy malaria [46]. Taken 
together, these studies highlight the potential roles of 
miRNAs in malaria infection.
Despite the fact that the presence of EVs-derived miR-
NAs has been demonstrated both in vitro and in experi-
mental cerebral malaria [47], according to the literatures 
available, no study has analysed EVs-derived miRNAs in 
human plasma. Thus, this present study examined the 
relative expression of selected miRNAs isolated from 
human plasma EVs. In the present study, the relative 
expression among three biological groups was compared, 
i.e., P. vivax-infected or P. falciparum-infected patients 
and uninfected individuals. The whole population of 
circulating EVs, namely microvesicles together with 
exosomes were analysed to gain a better understanding 
of the whole EV-bound miRNA population and to not 
restrict this analysis to one sub-population. By studying 
the EV compartment as a whole the chances of finding 
differences in miRNA expression between the groups 
would be increased. Five miRNA were selected based 
on previous in  vitro, animal model, or clinical studies 
that suggested these miRNAs had a potential involve-
ment in malaria, namely: hsa-miR-451a, hsa-miR-150-5p, 
hsa-miR-15b-5p, hsa-let-7a, and hsa-miR-16-5p [37–39, 
41–44, 48]. This study provides novel insight about circu-
lating EVs-derived miRNAs in human malaria.
Methods
Human samples collection and preparation
Malaria patients with P. falciparum or P. vivax were con-
firmed by microscopic examination by medical labora-
tory scientists at Buntharik district hospital in Ubon 
Rachathani. (Ethics approval by Ethics committee of 
the Faculty of Tropical Medicine, Mahidol University, 
MUTM 2012-046-05). Parasite species were identi-
fied and parasitaemia of each sample was calculated by 
counting the number of malaria-infected erythrocytes 
over the number of normal erythrocytes per thousand 
cells. Uninfected donors were recruited, and venipunc-
ture was performed for all donors using tri-potassium 
ethylenediaminetetraacetic acid (K3EDTA) as an antico-
agulant. K3EDTA blood samples were then centrifuged at 
1500×g for 15 min.
Then, platelet-free plasma samples were prepared by 
centrifugation at 13,000×g for 2  min at room tempera-
ture (RT) [17]. Supernatants were collected and stored at 
− 80  °C for further isolation of EVs. Samples were then 
shipped to the University of Technology Sydney where all 
experiments were performed.
Extracellular vesicles isolation from human plasma
500 µL of supernatants were mixed with 200 µL of 
sodium citrate and 300 µL of phosphate buffered saline 
(PBS) and then centrifuged at 150,000× g for 3  h at 
15  °C. Supernatants were discarded and pellets were 
resuspended in 100 µL sodium citrate and 900 µL PBS 
and subjected to centrifugation at 150,000×g for 3 h at 
15 °C.
Total RNA extraction
Pellets obtained after centrifugation were homogenized 
with 1 mL of RNAzol (Molecular Research Center, Inc) 
and 400 µL of UltraPure™ DNase/RNase-Free distilled 
water (Invitrogen ™). After a five-minute incubation 
at RT, they were centrifuged for 15 min at 12,000×g at 
4  °C. Supernatants were transferred to new tubes with 
800 µL isopropanol and 5 µL glycogen (5 mg/mL) then 
gently mixed. They were then placed at − 30  °C over-
night and spun for 10 min at 12,000×g at 4 °C the next 
day. Pellets were kept and washed with cold 75% etha-
nol to remove excess isopropanol, spun at 9000×g for 
3 min at 4 °C, the supernatant was discarded, and these 
steps were repeated twice. Later, excess ethanol was 
removed by spinning at 12,000×g for 30 s. RNA pellets 
were resolubilized with 10 µL of UltraPure™ DNase/
RNase-Free distilled water and heated for 5  min at 
55 °C. Lastly, they were vortexed and briefly spun down.
Total RNA concentration measurement and cleaning
RNA concentration was measured using the NanoDrop 
One Microvolume UV–Vis Spectrophotometer (Thermo 
Scientific™). If the quality of total RNA in the samples 
was not optimal, i.e., the Nanodrop flagged the result as 
phenol contamination or Absorbance 260/230 < 1.7, a 
sodium acetate (NaOAc), a cleaning step was performed. 
Briefly, 5 µL of glycogen (5 mg/mL) and 2.5 µL of sodium 
acetate (3  M pH5.5) were added to samples and mixed 
comprehensively. The mixture was supplemented with 
110 µL of absolute ethanol and incubated overnight in 
− 30  °C. Later, washing steps were performed as men-
tioned in the RNA extraction with RNAzol above.
Primers for miRNAs detection
All primers in this study was purchased from Thermo 
Fisher Scientific.
Five human miRNAs were used to perform quantita-
tive polymerase chain reaction as described in Table 1.
Reverse transcriptase quantitative polymerase chain 
reaction (RT‑qPCR)
As the NanoDrop was not sensitive enough to meas-
ure the RNA concentration, fixed volumes of RNA for 
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cDNA synthesis were used. To analyse miRNAs expres-
sion, 0.5 µL of total RNA was used for cDNA synthe-
sis. RT-qPCR was performed as per manufacturer 
protocol using  TaqMan® fast advanced master mix 
and  TaqMan® advanced miRNA assay. Quantitative 
PCR (qPCR) was run on the QuantStudio 6 flex system 
(Applied Biosystem) in triplicate together with distilled 
water as negative control.
Relative expression analysis
Only samples that had not been already freeze-thawed 
were included in the study to avoid RNA degradation. 
Comparative threshold cycle or quantification cycle  Cq 
(as described in [49]) method was used to analyse the 
qPCR data. Each sample was run in triplicates. Then, 
the average  Cq from the three  Cq values of those sam-
ples was calculated. To select one miRNA as an endog-
enous control, mean, standard deviation and variance 
for each miRNA analysed were calculated. ΔCq was then 
calculated using the following equation ΔCq = Cq of 
miRNA − Cq of endogenous control and relative expres-
sion was calculated by  2(−ΔΔCq) [50].
Target prediction and pathway involvement 
of dysregulated miRNAs
To predict possible targets of up-regulated miRNAs, 
the miRNAs of interest was submitted to Targetscan 
Release 7.2 and the predicted target genes were retrieved 
[51]. Then, the targets that overlapped genes involved in 
malaria pathway were obtained from the Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) [52]. In order to 
identify the pathways for individual and combined analy-
sis of miRNAs, DIANA-mirPath v3.0 was used, with a 5% 
false discovery rate (FDR) [53]. Fisher’s exact test (Hyper-
geometric distribution) was applied for enrichment anal-
ysis. The potential pathways were considered based on 
their p value (p < 0.05).
Evaluation of potential EVs‑derived miRNA as biomarker
Mean of Delta Cq for each miRNA was used in this anal-
ysis following the previous study [54]. The receiver oper-
ating characteristic (ROC) was calculated to propose the 
potential use of miRNAs as diagnostic tools. Area under 
the curve (AUC) was analysed to show the accuracy of 
the test with p-value of each analysis.
Statistical analysis
For the samples, demographic, mean age of each group 
was presented by average and standard deviation. All 
data was tested for their normality by using Kolmogo-
rov–Smirnov or Shapiro–Wilk tests and a non-paramet-
ric statistical analysis method was chosen. Comparison 
of parasitaemia percentage was achieved by the Mann–
Whitney U Test. Kruskal–Wallis test was used for 
comparison of relative expression of miRNAs in each bio-
logical group followed by post hoc analysis using Dunn’s 
test. Statistical significance for all tests was considered 
significant for α = 0.05. All statistical tests were analysed 
by Prism 8. All figures shown in this article were created 
by Prism 8 software for Mac, GraphPad Software, La Jolla 
California USA, https ://www.graph pad.com.
Results
Patient’s characteristics
57 plasma samples were included in this study divided 
into three groups; P. vivax-infected patients (n = 19), 
P. falciparum-infected patients (n = 18), and unin-
fected community individuals (n = 20) as per Table  2. 
The average age of malaria patients (Mean ± SD) was 
Table 1 Primers used for quantitative PCR
miRNAs NCBI accession 
number
Mature miRNAs sequences
hsa-miR-451a MI0001729 AAA CCG UUA CCA UUA CUG AGUU 
hsa-miR-15b-5p MI0000438 UAG CAG CAC AUC AUG GUU UACA 
hsa-miR-16-5p MI0000070 UAG CAG CAC GUA AAU AUU GGCG 
hsa-let-7a-5p MI0000060 UGA GGU AGU AGG UUG UAU AGUU 
hsa-miR-150-5p MI0000479 UCU CCC AAC CCU UGU ACC AGUG 
Table 2 Sample characteristic
* Mean and SD of age P. vivax-infected patients was calculated from 10 patients, Mean and SD of age of PF-infected patients was calculated from 15 patients
** %parasitaemia of P. vivax-infected patients calculated from 16 patients. %parasitaemia of PF-infected patients calculated from 14 patients
Characteristics PV‑infected patients PF‑infected patients Uninfected
Total number of patients 19 18 20
Gender
 Male 16 17 11
 Female 3 1 9
Age (Mean ± SD)* 31.6 ± 9.59 33.4 ± 11.91 21.8 ± 0.89
% Parasitaemia (Mean ± SD)** 0.35 ± 0.28 1.29 ± 1.48
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32.68 ± 11.08  years, P. vivax-infected patients was 
31.6 ± 9.59, and P. falciparum-infected patients was 
33.4 ± 11.91. The average age of uninfected individuals 
(21.8 ± 0.89  years) was significantly lower than both P. 
vivax-infected patients or P. falciparum-infected patients 
(p = 0.018, p = 0.001, respectively). Percentage of para-
sitaemia (% Parasitaemia) of P. VIVAX-infected patients 
was 0.35 ± 0.28 while P. falciparum-infected patients was 
1.29 ± 1.48. Overall parasitaemia was higher in P. falci-
parum-infected patients than P. vivax-infected patients 
(p = 0.0115) as shown in Fig. 1a.
Relative expression of miRNAs in three biological groups
Total RNA was extracted from EVs pellets and analysed 
hsa-miR-451a, hsa-miR-15b-5p, hsa-miR-16-5p, hsa-
let-7a-5p and hsa-miR-150-5p among P. vivax-infected 
patients, P. falciparum-infected patients and uninfected 
individuals. The average  Cq was calculated from tripli-
cate run (Fig. 1b). Hsa-miR-451a had the lowest  Cq with 
the minimum standard deviation compared to the other 
miRNAs, at 26.36 ± 2.33 (Mean ± SD). A Kruskal–Wallis 
test was undertaken to compare the Cq values in each 
biological group and showed that the values were not 
statistically different. These results indicated that this 
miRNA was the most stable among three biological 
groups and could be used as internal control. Moreover, 
previous studies demonstrated that hsa-miR-451a was 
highly expressed in both uninfected and parasitized red 
blood cells [32] and its expression was independent on 
the intra-erythrocytic development of the malaria para-
site [33].
In the present study, EVs were isolated from Thai 
patients presenting with uncomplicated malaria and 
demonstrated that miRNAs can be detected in these 
EVs. Descriptive statistics of Cq values are presented 
in Table  3. The relative expression of each miRNA was 
calculated using hsa-miR-451a as endogenous control 
using the  2(−ΔΔCq) method [50]. The relative expres-
sions of hsa-miR-15b-5p, hsa-miR-16-5p, hsa-let-7a-5p 
and hsa-let-7a-5p were compared between malaria-
infected (regardless of the parasite species) and unin-
fected individuals (Fig. 2). Hsa-miR-150-5p (p = 0.0054), 
Fig. 1 a Malaria infected patients with P. vivax or P. falciparum calculated as a percentage of parasitaemia. The average of parasitaemia was tested 
by Mann–Whitney U Test, which showed that the percentage of parasitaemia of those infected with P. falciparum is significantly higher than those 
with P. vivax (p = 0.0115). b miRNAs isolated from plasma-derived EVs were analysed by RT-qPCR (TaqMan™ Advanced miRNA Assays) with specific 
primers for hsa-miR-451a, hsa-miR-15b-5p, hsa-miR-16-5p, hsa-let-7a-5p and hsa-miR-150-5p. The plots show the average Cq values for each miRNA, 
and these values are compared between malaria infected patients and uninfected individuals. (Presented as standard error of mean, SEM)
Page 6 of 14Ketprasit et al. Malar J          (2020) 19:285 
hsa-miR-15b-5p (p = 0.0053) and hsa-let-7a-5p 
(p = 0.0002) were significantly up-regulated in EVs from 
malaria-infected patients comparing to the uninfected 
group. However, the relative expression of hsa-miR-16-5p 
between infected and non-infected individuals was not 
different.
Next, the changes in the abundance of these miR-
NAs were examined among the three biological groups 
(Fig. 3). An up-regulation of hsa-miR-150-5p (p = 0.0119) 
and hsa-miR-15b-5p (p = 0.0052) was observed in EVs 
from P. vivax-infected patients. Remarkably, hsa-let-
7a-5p expression was higher in both P. vivax-infected 
patients and P. falciparum-infected patients (p = 0.0025, 
p = 0.0145, respectively). When those parameters were 
compared between P. vivax-infected patients and P. fal-
ciparum-infected patients, there was no difference. The 
descriptive analysis of each miRNA in each group is pre-
sented in Table 4.
Target prediction and KEGG Pathway analysis 
of hsa‑miR150‑5p and hsa‑miR‑15b‑5p
In order to study the possible roles of up-regulated 
miRNAs in malaria patients, the prediction was made 
using Targetscan. These targets were later overlapped 
with genes involved in the biological pathways that are 
relevant to malaria. There were 15, 5, and 6 targets of 
hsa-miR-150-5p, hsa-miR-15b-5p, and hsa-let-7a-5p, 
respectively as shown in Additional file 1: Table S1. Some 
targets were regulated by more than one miRNA of inter-
est. Hepatocyte growth factor (HGF) encoding gene was 
regulated by all up-regulated miRNAs. Toll-like receptor 
4 (TLR4), interleukin 10, and thrombospondin-1 were 
found regulated by hsa-miR-150-5p and hsa-let-7a-5p.
Table 3 Descriptive statistics of  quantification cycle  (Cq) 
values
miRNAs Min Cq Max Cq Mean ± SD Coefficient 
of variation 
(%)
hsa-miR-451a 20.43 30.63 26.36 ± 2.33 8.84
hsa-miR-15b-5p 24.57 34.77 30.06 ± 2.34 7.77
hsa-miR-16-5p 22.96 33.57 29.20 ± 2.65 9.09
hsa-let-7a-5p 24.57 34.19 31.17 ± 2.15 6.91
hsa-miR-150-5p 24.07 33.54 28.78 ± 2.37 8.24
Fig. 2 Relative expression of hsa-miR-15b-5p, hsa-miR-16-5p, hsa-let-7a-5p and hsa-miR-150-5p were calculated using  2(−ΔΔCq) method. The dot 
plots represent  2(−ΔΔCq) values of each miRNA (Mean and SEM). Mann–Whitney U Test was performed to demonstrate the different abundance of 
hsa-miR-150-5p, hsa-miR-15b-5p, and hsa-let-7a-5p in malaria compared to uninfected individuals (p = 0.0054, p = 0.0053, p = 0.0002, respectively). 
The horizontal line denotes the average value and SEM bar
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Next, to get insight into these up-regulated miRNAs, a 
KEGG pathway analysis was performed using DIANA-
mirPath v3.0 that searches against experimentally vali-
dated miRNAs targets on Tarbase v7.0. The pathway 
analysis revealed 10, 22, and 32 pathways that were sta-
tistically overrepresented by targeted genes of hsa-miR-
150-5p, hsa-miR-15b-5p, and hsa-let-7a-5p, respectively. 
When the combined analysis of up-regulated miRNAs 
was determined, there were 44 enriched pathways. Of 
those enrichment pathways, the overlapped pathways 
included adherens junction (5th in the list, p = 2.52E−10) 
as well as TGF-beta signaling pathway (11th in the list, 
p = 1.64E−7). Other important pathways that might 
engage in malaria were extracellular matrix (ECM)-
receptor interaction (14th in the list, p = 0.0005), FoxO 
signaling pathway (29th in the list, p = 0.0332) and HIF-1 
signaling pathway (30th in the list, p = 0.0353). In Fig. 4, 
the top 10 enriched pathways analysis were presented 
according to their ranks based on p-value.
Evaluation of the diagnostic potential of extracellular 
vesicles‑derived miRNAs
In addition, this study aimed to investigate whether the 
EVs-bound miRNAs could be used as putative diagnostic 
Fig. 3 This dot plot demonstrates the miRNAs expression values in 3 biological groups (Uninfected, P. vivax-infected patients or P. vivax, and P. 
falciparum-infected patients or P. falciparum). The Kruskal–Wallis was tested and followed by post hoc analysis using Dunn’s test. hsa-miR-150-5p, 
hsa-miR-15b-5p were significantly up-regulated in P. vivax (p = 0.0119, p = 0.0052, respectively). Relative expression of hsa-let-7a-5p was higher in 
both P. vivax and P. falciparum (p = 0.0025, p = 0.0145, respectively). The horizontal line denotes the average value and SEM bar
Table 4 Relative expression analysis of miRNAs
ΔCq (Mean ± SD) 2(− ΔΔCq) Mean 
(Mean ± SD)
hsa-let-7a-5p
 Uninfected 6.23 ± 1.91 1.28 ± 1.10
 PV 4.09 ± 1.17 5.68 ± 3.85
 PF 4.26 ± 1.32 5.76 ± 5.52
hsa-miR-15b-5p
 Uninfected 5.34 ± 1.49 1.43 ± 1.07
 PV 3.29 ± 1.17 5.45 ± 3.96
 PF 4.33 ± 1.68 3.51 ± 4.04
hsa-miR-16-5p
 Uninfected 2.79 ± 1.22 1.44 ± 1.47
 PV 2.56 ± 0.72 1.31 ± 0.64
 PF 3.21 ± 1.32 1.00 ± 0.60
hsa-miR-150-5p
 Uninfected 3.39 ± 1.44 1.37 ± 0.86
 PV 1.54 ± 1.64 6.32 ± 7.23
 PF 2.33 ± 1.49 3.20 ± 3.07
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markers. The ROC was used, and the AUC was calculated 
for each miRNA in both P. falciparum-infected patients 
and P. vivax-infected patients. Three miRNAs showed a 
statistical significance in the P. vivax-infected patients. 
hsa-miR-150-5p AUC was 0.7794 (p = 0.0062), hsa-miR-
15b-5p AUC was 0.8766 (p = 0.0015) and hsa-let-7a 
was 0.8375 (p = 0.0014). In the P. falciparum-infected 
patients, only hsa-let-7a-5p was statistically significant 
with AUC 0.8221 (p = 0.0033). Area under the ROC was 
shown with 95% confidence interval value (Fig. 5).
Discussion
The present study, demonstrated that miRNAs can be 
detected in EVs were isolated from the blood of both 
Thai patients presenting with uncomplicated malaria and 
healthy donors. The miRNAs selected included hsa-miR-
451a, hsa-miR-15b-5p, hsa-miR-16-5p, hsa-let-7a-5p 
and hsa-miR-150-5p that were previously analysed in 
the context of malaria [37–39, 41–44, 48]. As mentioned 
earlier, hsa-miR-451a was selected as endogenous con-
trol as its Cq values were the most stable among three 
groups. In contrast, Chamnanchanunt et  al. found that 
hsa-miR-451a was down-regulated in P. vivax-infected 
patient plasma [44]. Other studies demonstrated that EVs 
cargo hsa-miR-451a could be internalized to target the 
parasites and diminish the parasite burden [38, 43]. Fur-
thermore, in an in vitro study, red blood cell derived EVs 
containing hsa-miR-451a and human argonaute 2 (Ago2) 
were shown to be internalized by endothelial cells. This 
miR-Ago2 could down-regulate the expression of CAV-1 
and ATF2 resulting in endothelial cells alteration which 
is a plausible factor contributing vascular dysfunction 
in cerebral malaria [42]. As various studies showed that 
EVs that cargo hsa-miR-451a could be taken up by vari-
ous cells in the context of malaria, it would, therefore, be 
interesting to enumerate the number of EVs and compare 
it with the change in abundance of hsa-miR-451a.
The hsa-miR-15b-5p and hsa-miR-150-5p were up-
regulated in the plasma-derived EVs from P. vivax-
infected patients but not in the P. falciparum-infected 
patients. An analysis of miRNAs from whole blood of 
adult imported falciparum malaria showed a down regu-
lation of hsa-miR-150-5p [48]. Kaur et al. have identified 
a potential biomarker for differential diagnosis between 
uncomplicated and complicated P. vivax malaria infec-
tion, hsa-miR-7977. In addition, an increase in this 
miRNA was predicted to be involved in malaria patho-
genesis through the transforming growth factor beta 
(TGF-β) signaling pathway [48]. Recently, a study in non-
human primate (Aotus lemurinus lemurinus) confirmed 
that bone marrow is an important reservoir for gameto-
cytogenesis and proliferation of P. vivax [55]. A study in 
bone marrow aspirate of human diagnosed with P. vivax 
showed an aberrant expression of miRNAs in CD71 posi-
tive erythroid cells during infection, hsa-miR-150 and 
hsa-miR-16 were down-regulated while hsa-miR-144 was 
increased. However, hsa-miR-451a, the most abundant 
erythroid miRNA, remained stable [56]. In experimental 
cerebral malaria (ECM), an investigation in brain tissue 
found a higher expression of miR-150 while microvesicles 
from ECM mice showed non statistically different change 
of miR-150 expression [39, 47]. Nonetheless, this pre-
sent study only investigated the plasma from the patients 
before drug administration and the clinical manifestation 
after treatment were not followed. Taken together, these 
data suggest that hsa-miR-150-5p might be an essential 
miRNA involved in malaria infection.
The relative expression of hsa-miR-15b-5p was higher 
in EVs from P. vivax-infected patients. To date, there is 
no evidence about the altered expression of this miRNA 
which might link to P. vivax malaria. However, this 
miRNA is present in P. falciparum in vitro and its abun-
dance was decreased following infection. Also, it was 
potentially predicted to form a chimeric fusion with ring-
infected erythrocyte surface antigen (RESA) [38]. Even 
though the relative expression of this miRNA was not sta-
tistically significant in P. falciparum-infected patients, it 
was noticed in this study that it was slightly higher when 
this miRNA was compared with the uninfected group.
Next, the relative expression of hsa-let-7a, which 
was found in infected erythrocytes [33], was deter-
mined. The relative abundance of hsa-let-7a was signifi-
cantly increased in both P. vivax-infected patients and 
P. falciparum-infected patients compared to uninfected 
controls. these results are in accordance with previ-
ous studies showing that this miRNA could be detected 
in EVs and might be derived from parasitized red blood 
cells [41, 42]. It is noteworthy that the overall expression 
of this miRNA is higher in the malaria patients (regard-
less of the parasite) than in uninfected donors. Several 
studies demonstrated that hsa-let-7a plays a role in host-
parasite interaction [37, 41]. This miRNA in complex 
(See figure on next page.)
Fig. 4 Pathway enrichment analysis of up-regulated miRNAs were carried out by DIANA-mirPath v3.0 which searching against experimentally 
validated miRNAs targets on Tarbase v7.0. The combinatorial effect of up-regulated miRNAs was determined. Of those enriched pathways, the 
malaria-relevant pathways was found including adherens junction and TGF-beta signaling pathway. The bar chart presents with top 10 enriched 
pathway. The horizontal lines present -log10 p-values
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Fig. 5 Area Under the Receiver Operating Characteristic (ROC) curve (AUC) analysis. The AUC of each tests presents with the maximum AUC. In 
P. vivax-infected patients, hsa-miR-150-5p AUC was 0.7794 (p = 0.0062), hsa-miR-15b-5p AUC was 0.8766 (p = 0.0015), and hsa-let-7a was 0.8375 
(p = 0.0014). For the P. falciparum-infected patients, there was the hsa-let-7a-5p that was statistically significant with AUC 0.8221 (p = 0.0033)
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with Ago2 [41] could be detected in P. falciparum and 
potentially targets the Plasmodium gene: Rad54 [37]. 
In addition, hsa-let-7a expression was low in erythro-
cyte-derived EVs in a P. falciparum in  vitro experiment 
but another member in the let7 family: hsa-let-7b was 
higher in the EVs fraction compared to infected or unin-
fected erythrocytes. Interestingly, miRNAs profiling from 
in  vitro P. falciparum infected erythrocyte-derived EVs 
also showed that hsa-let-7a, hsa-let-7i, hsa-let-7  g and 
hsa-let-7f were highly expressed [42]. Some of these miR-
NAs might derive from parasitized red blood cells as they 
were found highly enriched in previous analyses [33]. In 
addition, a study in experimental cerebral malaria dem-
onstrated an increased expression of let-7i in brain tis-
sues which might link to cerebral malaria pathogenesis 
[39]. This implies that miRNAs within the let-7 family 
might play a role in the parasite biology, malaria patho-
genesis and further studies should be performed to eluci-
date their functions.
Furthermore, the relative expression of hsa-miR-16-5p 
was analysed. There was no change in the abundance 
both in P. vivax-infected patients and P. falciparum-
infected patients when compared to uninfected individu-
als. This is consistent with two previous studies showing 
that hsa-miR-16-5p is highly expressed in both P. falci-
parum-infected erythrocytes and normal erythrocytes. 
Thus, the relative expression of this miRNA might not be 
modulated during infection. However, these results dif-
fer from a study that found down-regulation of hsa-miR-
16-5p in P. vivax-infected patients [44]. Interestingly, 
a previous study using an ECM model (P. berghei strain 
ANKA) found an up-regulation of miR-16 in plasma-
derived microvesicles [47] suggesting that further stud-
ies are needed to elucidate the expression of this miRNA 
during complicated and uncomplicated malaria infection.
Several pathways might be important in the context 
of malaria. Importantly, the adherens junction and the 
transforming growth factor (TGF)-β were found enriched 
by the targeted genes of 3 dysregulated miRNAs. Adher-
ens junctions are possibly regulated by hsa-miR-150-5p, 
hsa-miR-15b-5p and hsa-let-7a-5p. The blood–brain 
barrier (BBB) is a vital compartment of central nervous 
system as it separates the CNS from surrounding envi-
ronment. Adherens junctions in endothelial cells par-
ticipate to the forming and maintaining of the integrity 
of the BBB. A number of studies also showed that some 
miRNAs might regulate this type of junction. For exam-
ple, the down regulation of vascular endothelium cad-
herin (VE-Cadherin) was affected by overexpression of 
miR-101 and this lead to HIV-associated neurological 
disorder [57]. Also, the overexpression of miR-142-3p 
repressed the expression of VE-Cadherin and impaired 
vascular integrity in zebrafish [58]. Similarly, in ECM, the 
authors postulated the roles of overexpressed miR-19a-3p 
and miR-19b-5p in this pathway as well [40]. Knowing 
the roles of miRNAs in the context of malaria particu-
larly cerebral malaria pathogenesis is paramount as it 
might lead to the development of an adjunctive therapy. 
For instance, inhibition of miR-27 could prevent vascu-
lar leakage associated with ischaemia [59]. However, no 
study of the dysregulated miRNAs analysed in this work, 
which are in association with this pathway, has been per-
formed in human malaria. More studies are therefore 
needed to fill this gap.
Circulating miRNAs have been studied and proposed 
as diagnostic biomarkers in many infectious diseases 
including malaria. Most studies on infectious diseases 
have detected human miRNAs such as those in tuber-
culosis [60], hepatitis B [61], schistosomiasis [62] while 
some studies investigated microbial miRNAs as biomark-
ers as well [54, 63–65]. Despite the fact that Plasmo-
dium spp. lack RNA interference machinery and its own 
miRNAs [32, 36], human derived miRNAs were demon-
strated as promising biomarkers [44, 48]. For example, 
in human malaria, hsa-miR-16 and hsa-miR-451a were 
proposed to be biomarkers for P. vivax infection diag-
nosis [44]. In the present study, the potential of miRNAs 
isolated from EVs in malaria patients was evaluated for 
the first time. The calculated p-values from AUC analysis 
indicated that hsa-miR-150-5p, hsa-miR-15b-5p might 
be used as biomarkers for P. vivax malaria whereas hsa-
let-7a-5p might be used to test for both P. vivax and P. 
falciparum malaria. However, the sensitivity and speci-
ficity were not much higher. Therefore, further analysis 
of these miRNAs is recommended because the number 
of patient samples were relatively low in this study. Fur-
thermore, as mentioned earlier, this study selected the 
miRNAs based on previous studies that investigated 
these miRNAs in the context of malaria. A more in-depth 
study is needed to develop new biomarkers. For instance, 
profiling miRNA using microarrays or next-generation 
sequencing will allow an evaluation of all miRNAs pre-
sent in the EVs. Also, these miRNAs should be analysed 
in the patients after they recover from the disease. It 
might be useful in the context of P. vivax malaria as this 
species can cause relapse infection. In addition, these 
markers should be further analysed and compared in the 
different groups of P. falciparum malaria patients such as 
uncomplicated and severe malaria. These will be useful if 
patients can be early predicted the chance of developing 
severe malaria beforehand.
Conclusion
This novel study explored hsa-miR-150-5p, hsa-miR-
15b-5p, hsa-let-7a-5p, and hsa-miR-16-5p which were 
isolated from EVs from Thai malaria patient’s plasma. 
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The relative expression of hsa-miR-150-5p and hsa-miR-
15b-5p were significantly higher in P. vivax-infected 
patients where hsa-let-7a-5p was significantly up-reg-
ulated in both P. vivax-infected patients and P. falcipa-
rum-infected patients. Targets prediction and pathways 
enrichment analysis also provided the possible roles of 
these up-regulated miRNAs in the context of malaria, 
especially the TGF- β pathway, which need further inves-
tigation to elucidate their exact roles in the malaria biol-
ogy and the disease pathogenesis.
As this current study only evaluated those miRNAs 
from EVs of uncomplicated malaria patients, it is there-
fore encouraging to analyse in the future the EVs-derived 
miRNAs in those patients with severe complications.
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